Malignant triton tumor of the retroperitoneum: a case report and review of the literature

被引:17
作者
Li, Zhiwei [1 ,2 ,3 ]
Xiang, Jie [1 ,2 ,3 ]
Yan, Sheng [1 ,2 ,3 ]
Gao, Feng [1 ,2 ,3 ]
Zheng, Shusen [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Organ Transplantat Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Malignant triton tumor; Retroperitoneum; Surgery; Prognosis; RHABDOMYOSARCOMATOUS DIFFERENTIATION; NEUROFIBROMATOSIS TYPE-1; SURVIVAL; HEAD;
D O I
10.1186/1477-7819-10-96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Malignant triton tumors are relatively rare and highly aggressive tumors in which malignant schwannoma cells coexist with rhabdomyoblasts. Their occurrence in the retroperitoneum is uncommon and has been rarely reported. Case presentation: We present the case of a patient with a retroperitoneal malignant triton tumor. A 32-year-old male was referred with epigastric pain and an abdominal mass. Computed tomography revealed a huge soft tissue retroperitoneal mass that involved adjacent organs and vessels. Complete resection was undertaken. Pathological examination confirmed the presence of a malignant triton tumor. The patient died two and a half months after surgery, as a result of local recurrence. Conclusion: Malignant triton tumors are uncommon sarcomas that are associated with a high incidence of developing local recurrence and distant metastases. Immunohistochemical staining showing nerve sheath differentiation with rhabdomyoblastic cells confirms the diagnosis. Complete excision of the tumor is the most effective treatment strategy for these retroperitoneal tumors.
引用
收藏
页数:6
相关论文
共 28 条
[1]  
BROOKS JSJ, 1985, CANCER-AM CANCER SOC, V55, P2543, DOI 10.1002/1097-0142(19850601)55:11<2543::AID-CNCR2820551105>3.0.CO
[2]  
2-4
[3]  
Coindre JM, 2006, ARCH PATHOL LAB MED, V130, P1448
[4]  
DAGOSTINO AN, 1963, CANCER-AM CANCER SOC, V16, P1003, DOI 10.1002/1097-0142(196308)16:8<1003::AID-CNCR2820160807>3.0.CO
[5]  
2-S
[6]   MALIGNANT TRITON TUMORS - A CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY OF 9 CASES [J].
DAIMARU, Y ;
HASHIMOTO, H ;
ENJOJI, M .
HUMAN PATHOLOGY, 1984, 15 (08) :768-778
[7]  
DUCATMAN BS, 1984, CANCER-AM CANCER SOC, V54, P1049, DOI 10.1002/1097-0142(19840915)54:6<1049::AID-CNCR2820540620>3.0.CO
[8]  
2-1
[9]  
ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106
[10]  
Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182